Best Haploidentical Stem Cell Transplantation doctors in Israel: TOP 14 doctors

Dr. Ram Ron specializes in Haploidentical Stem Cell Transplantation at Sourasky Medical Center (Ichilov).

• Over 24 years of experience of experience in the field
• Fellowship-trained at Ronald O Perelman and Claudia Cohen Centre
• Specializes in complex reproductive medicine techniques

300+ stem cell transplantations – Dr. Ronit El Hasid heads pediatric oncohematology at Dana Dwek Children’s Hospital, a leader in the field.

• Specializes in bone marrow and umbilical cord blood transplants for children
• Published 50 research papers and 40 conference reports
• Trained at City of Hope Hospital in Los Angeles
• Member of American Hematology Association

Dr. Ron Ram has performed several hundred stem cell transplants at Sourasky Medical Center, specializing in haploidentical procedures.

• Board-certified in Internal Medicine, Hematology, and Medical Oncology
• Completed fellowship in Hematology and Oncology at New York Medical College
• Published over 30 scientific articles on hematology and oncology
• Contributed a chapter to a medical textbook

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Michael Shapira specializes in Bone Marrow Transplantation at Sourasky Medical Center (Ichilov), with extensive experience in haploidentical stem cell procedures.

• Graduated from Hebrew University Medical School in 1999
• Specialized in internal medicine at Hadassah Medical Center
• Senior physician in Bone Marrow Transplantation department at Hadassah
• Fluent in English and Hebrew for patient communication

Dr. Dror Levin specializes in innovative treatments for pediatric blood disorders and bone cancer, focusing on complex cases at Sourasky Medical Center.

• Director of pediatric hematology oncology at Sourasky Medical Center
• Member of the Israel Society of Pediatric Hematology-Oncology (ISPHO)
• Trained at leading institutions including Rizzoli Orthopaedic Institute in Italy
• Coordinates treatment for bone cancer (sarcoma) in children

With 34 years of experience of dedication to oncohematology, Dr. Aviv specializes in complex blood disorders at Sourasky Medical Center (Ichilov Clinic).

• Specializes in haploidentical stem cell transplantation
• Extensive experience with rare and challenging cases
• Works at a leading medical center in Israel

Leading expert in chronic lymphocytic leukemia – Dr. Herishanu Yair has received multiple awards for his hematology research and clinical work.

• Board-certified hematologist with over 24 years of experience of experience
• Recipient of the Klitzberg Oncology Award from the American Physician Fellowship
• Member of both the Israeli and American Hematology Associations
• Trained at top medical centers including Tel Aviv Medical Center

Dr. Danylesko specializes in haploidentical stem cell transplantation at Sheba Medical Center, a leader in innovative transplant techniques.

• Served as a senior clinician in hematology and bone marrow transplantation
• Expertise in managing graft-versus-host disease
• International experience with complex transplant cases

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.